About Genor

Genor Biopharma Co. Ltd. was founded in December 2007. It is an innovation-driven international biopharmaceutical company, focusing on development and commercialization of therapeutic monoclonal antibodies (mAbs), Fc-fusion proteins and recombinant therapeutic proteins. Currently Genor has more than 10 products in pipeline, ten of which have entered clinical stage.

Business Development

Genor Biopharma has several product in the clinical and preclinical stage (including biosimilar and innovative drugs). We are activily seeking collaboration partnerships to co-develop emerging market and EU/US markets.

If you are interested in such collaboration opportunities, please contact our business development department. We are sincerly looking forward to the partnership oportunites to enrich our pipeline, and t o accelerate product development  and commercialization.

Email: bd_genor@walvax.com

Contact Us


Genor Biopharma Co., Ltd.

Building 3, 1690 Zhangheng Rd., Pudong, Shanghai, China 201203

Tel: +86 21 6069 0700 Ext. 55567

Fax: +86 21 6075 1991

Website: www.genorbio.com